Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yixun, Lu"'
Autor:
Yixun Lu, Guoxiao Liu, Yanjun Wang, Kai Li, Xinxin Xu, Benlong Zhang, Lin Chen, Hongqing Xi, Xinxin Wang
Publikováno v:
MedComm – Oncology, Vol 2, Iss 2, Pp n/a-n/a (2023)
Abstract Gastric cancer (GC) is one of the most commonly diagnosed malignancies worldwide. Compelling evidence indicates that circular RNA (circRNA) played critical roles in multiple cancers. However, the role and mechanisms of circRNAs in GC remains
Externí odkaz:
https://doaj.org/article/572b791ecd324a41bf7e276718184e5a
Autor:
Qiying Song, Xiongguang Li, Di Wu, Shuo Li, Tianyu Xie, Yixun Lu, Liyu Zhang, Ziyao Xu, Lu Liu, Xin Guo, Xinxin Wang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background To date, Siewert type II adenocarcinoma of the esophagogastric junction (ST-II AEG) can be removed radically utilizing either the abdominal-transhiatal (TH) or the right thoracoabdominal (RTA) approaches. Because of a paucity of h
Externí odkaz:
https://doaj.org/article/c4bfe3f62d6e46989cb683e6879cec35
Autor:
Yixun Lu, Benlong Zhang, Baohua Wang, Di Wu, Chuang Wang, Yunhe Gao, Wenquan Liang, Hongqing Xi, Xinxin Wang, Lin Chen
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-15 (2021)
Abstract Background Gastric cancer (GC) is the fifth most commonly diagnosed cancer worldwide. Due to the dismal prognosis, identifying novel therapeutic targets in GC is urgently needed. Evidences have shown that miRNAs played critical roles in the
Externí odkaz:
https://doaj.org/article/a1bcbab6eae8419fa3df02e6a5e28a3f
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPlatelet activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) is associated with a variety of human diseases. However, its function in gastric cancer remains uncertain.MethodsPAFAH1B3 expression was analyzed in The Cancer Gen
Externí odkaz:
https://doaj.org/article/54ba303d0bb64235b331a7e41265191a
Autor:
Chuang, Wang, Yunhe, Gao, Wenquan, Liang, Yixun, Lu, KeCheng, Zhang, Di, Wu, ZiWei, Zhuang, Kai, Li, Zhi, Qiao, Hongqing, Xi, Lin, Chen
Publikováno v:
Biochemical and Biophysical Research Communications. 627:91-96
Gastric cancer is a one of the most common malignant tumors with poor prognosis worldwide. Leucine-rich G-protein-coupled receptor 5 (LGR5) is determined as a modulator of Wnt signaling cascade and R-spondins are a family of secretory agonists in the
Autor:
Di Wu, Tianyu Xie, Shuo Li, Yixun Lu, Xiongguang Li, Qiying Song, Benlong Zhang, Liyu Zhang, Xinxin Wang
Publikováno v:
Science of Advanced Materials. 14:80-85
The incidence of digestive system tumors has been increasing in recent years. Gastric cancer (GC) is one of leading causes of cancer-related mortality. Although a lot of research has been conducted, the effect of GC treatment is still not good. Ptero
Publikováno v:
FEBS Letters. 595:2644-2654
Gastric cancer (GC) has a dismal prognosis and is also one of the most commonly diagnosed malignancies worldwide. circRNAs are covalently closed circular RNA molecules without 5'-cap and a 3'-tail, currently listed among the broad noncoding RNA famil
Publikováno v:
Cancer Management and Research. 12:4347-4356
Introduction Long non-coding RNA (lncRNA) DSCAM-AS1 was reported to be aberrantly expressed and play pivotal roles in various human cancers. The aim of the present study was to investigate the expression and roles of DSCAM-AS1 in colon cancer (CC). M
Autor:
Yixun Lu, Song Qiying, Shuo Li, Xinxin Wang, Di Wu, Wang Lipeng, Sun Xuehong, Tianyu Xie, Xiongguang Li
Publikováno v:
Cancer Management and Research. 12:5201-5212
Background The dysregulation of microRNA (miRNAs) is broadly participated in cancer progression, resulting in sustained cell proliferation by directly targeting various targets. This study investigated the expression of miR-582 in GC and its associat
Autor:
Qiying Song, Xiongguang Li, Di Wu, Shuo Li, Tianyu Xie, Yixun Lu, Liyu Zhang, Ziyao Xu, Lu Liu, Xin Guo, Xinxin Wang
Publikováno v:
BMC cancer. 22(1)
Background To date, Siewert type II adenocarcinoma of the esophagogastric junction (ST-II AEG) can be removed radically utilizing either the abdominal-transhiatal (TH) or the right thoracoabdominal (RTA) approaches. Because of a paucity of high-quali